Biomed outfit readies for US

LOCAL ASX-listed biomedical company Xcell Diagnostics hopes to operate a US subsidiary by the end of the year to open up the American market for its revolutionary skin cancer detection device developed by its recent acquisition, German medical technology company Visiomed AG.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
49 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer